289 related articles for article (PubMed ID: 30507471)
1. Resolving gastric cancer aetiology: an update in genetic predisposition.
Lott PC; Carvajal-Carmona LG
Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):874-883. PubMed ID: 30507471
[TBL] [Abstract][Full Text] [Related]
2. Germline Mutations in PALB2, BRCA1, and RAD51C, Which Regulate DNA Recombination Repair, in Patients With Gastric Cancer.
Sahasrabudhe R; Lott P; Bohorquez M; Toal T; Estrada AP; Suarez JJ; Brea-Fernández A; Cameselle-Teijeiro J; Pinto C; Ramos I; Mantilla A; Prieto R; Corvalan A; Norero E; Alvarez C; Tapia T; Carvallo P; Gonzalez LM; Cock-Rada A; Solano A; Neffa F; Della Valle A; Yau C; Soares G; Borowsky A; Hu N; He LJ; Han XY; ; Taylor PR; Goldstein AM; Torres J; Echeverry M; Ruiz-Ponte C; Teixeira MR; Carvajal-Carmona LG
Gastroenterology; 2017 Apr; 152(5):983-986.e6. PubMed ID: 28024868
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of PALB2-associated breast cancers.
Lee JEA; Li N; Rowley SM; Cheasley D; Zethoven M; McInerny S; Gorringe KL; James PA; Campbell IG
J Pathol; 2018 May; 245(1):53-60. PubMed ID: 29431189
[TBL] [Abstract][Full Text] [Related]
4. Investigation on the Role of PALB2 Gene in CDH1-Negative Patients With Hereditary Diffuse Gastric Cancer.
Carreño M; Pena-Couso L; Mercadillo F; Perea J; Urioste M
Clin Transl Gastroenterol; 2020 Dec; 11(12):e00280. PubMed ID: 33512806
[TBL] [Abstract][Full Text] [Related]
5. Germline mutations of PALB2 gene in a sequential series of Chinese patients with breast cancer.
Zhang K; Zhou J; Zhu X; Luo M; Xu C; Yu J; Deng M; Zheng S; Chen Y
Breast Cancer Res Treat; 2017 Dec; 166(3):865-873. PubMed ID: 28825143
[TBL] [Abstract][Full Text] [Related]
6. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
Alter BP; Best AF
Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
[TBL] [Abstract][Full Text] [Related]
7. Gastric cancer genetic predisposition and clinical presentations: Established heritable causes and potential candidate genes.
Garcia-Pelaez J; Barbosa-Matos R; São José C; Sousa S; Gullo I; Hoogerbrugge N; Carneiro F; Oliveira C
Eur J Med Genet; 2022 Jan; 65(1):104401. PubMed ID: 34871783
[TBL] [Abstract][Full Text] [Related]
8. Gene panel sequencing in familial breast/ovarian cancer patients identifies multiple novel mutations also in genes others than BRCA1/2.
Kraus C; Hoyer J; Vasileiou G; Wunderle M; Lux MP; Fasching PA; Krumbiegel M; Uebe S; Reuter M; Beckmann MW; Reis A
Int J Cancer; 2017 Jan; 140(1):95-102. PubMed ID: 27616075
[TBL] [Abstract][Full Text] [Related]
9. Gastric cancer and family history.
Choi YJ; Kim N
Korean J Intern Med; 2016 Nov; 31(6):1042-1053. PubMed ID: 27809451
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
11. The Role of PALB2 in the DNA Damage Response and Cancer Predisposition.
Nepomuceno TC; De Gregoriis G; de Oliveira FMB; Suarez-Kurtz G; Monteiro AN; Carvalho MA
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28858227
[TBL] [Abstract][Full Text] [Related]
12. Detection of novel germline mutations in six breast cancer predisposition genes by targeted next-generation sequencing.
Dong L; Wu N; Wang S; Cheng Y; Han L; Zhao J; Long X; Mu K; Li M; Wei L; Wang W; Zhang W; Cao Y; Liu J; Yu J; Hao X
Hum Mutat; 2018 Oct; 39(10):1442-1455. PubMed ID: 30039884
[TBL] [Abstract][Full Text] [Related]
13. PALB2 Variants: Protein Domains and Cancer Susceptibility.
Nepomuceno TC; Carvalho MA; Rodrigue A; Simard J; Masson JY; Monteiro ANA
Trends Cancer; 2021 Mar; 7(3):188-197. PubMed ID: 33139182
[TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition to gastric cancer.
Petrovchich I; Ford JM
Semin Oncol; 2016 Oct; 43(5):554-559. PubMed ID: 27899187
[TBL] [Abstract][Full Text] [Related]
15. Spectrum of PALB2 germline mutations and characteristics of PALB2-related breast cancer: Screening of 16,501 unselected patients with breast cancer and 5890 controls by next-generation sequencing.
Zhou J; Wang H; Fu F; Li Z; Feng Q; Wu W; Liu Y; Wang C; Chen Y
Cancer; 2020 Jul; 126(14):3202-3208. PubMed ID: 32339256
[TBL] [Abstract][Full Text] [Related]
16. Germline CDH1 mutations are a significant contributor to the high frequency of early-onset diffuse gastric cancer cases in New Zealand Māori.
Hakkaart C; Ellison-Loschmann L; Day R; Sporle A; Koea J; Harawira P; Cheng S; Gray M; Whaanga T; Pearce N; Guilford P
Fam Cancer; 2019 Jan; 18(1):83-90. PubMed ID: 29589180
[TBL] [Abstract][Full Text] [Related]
17. Frequency of mutations in BRCA genes and other candidate genes in high-risk probands or probands with breast or ovarian cancer in the Czech Republic.
Riedlova P; Janoutova J; Hermanova B
Mol Biol Rep; 2020 Apr; 47(4):2763-2769. PubMed ID: 32180084
[TBL] [Abstract][Full Text] [Related]
18. Targeted massively parallel sequencing characterises the mutation spectrum of PALB2 in breast and ovarian cancer cases from Poland and Ukraine.
Myszka A; Nguyen-Dumont T; Karpinski P; Sasiadek MM; Akopyan H; Hammet F; Tsimiklis H; Park DJ; Pope BJ; Slezak R; Kitsera N; Siekierzynska A; Southey MC
Fam Cancer; 2018 Jul; 17(3):345-349. PubMed ID: 29052111
[TBL] [Abstract][Full Text] [Related]
19. Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy.
Rizzolo P; Zelli V; Silvestri V; Valentini V; Zanna I; Bianchi S; Masala G; Spinelli AM; Tibiletti MG; Russo A; Varesco L; Giannini G; Capalbo C; Calistri D; Cortesi L; Viel A; Bonanni B; Azzollini J; Manoukian S; Montagna M; Peterlongo P; Radice P; Palli D; Ottini L
Int J Cancer; 2019 Jul; 145(2):390-400. PubMed ID: 30613976
[TBL] [Abstract][Full Text] [Related]
20. Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.
Graffeo R; Livraghi L; Pagani O; Goldhirsch A; Partridge AH; Garber JE
Breast Cancer Res Treat; 2016 Dec; 160(3):393-410. PubMed ID: 27734215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
